Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
Time-resolved single cell transcriptomics of an ibrutinib-treated mantle cell lymphoma cell line
GEO Series GSE162234. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
ClinicalTrials.gov study NCT03535350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02553941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Buparlisib and Ofatumumab or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02614508. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT02940301. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02635074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT05963074. IPD Sharing: YES. Countries: 8. Publications: 0.
Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA Capsules
ClinicalTrials.gov study NCT02841150. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL
ClinicalTrials.gov study NCT03502876. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy
ClinicalTrials.gov study NCT01599949. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
ClinicalTrials.gov study NCT03379428. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone
ClinicalTrials.gov study NCT02815059. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
ClinicalTrials.gov study NCT04514393. IPD Sharing: NO. Countries: 1. Publications: 0.
Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)
ClinicalTrials.gov study NCT03964090. IPD Sharing: YES. Countries: 1. Publications: 0.
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
ClinicalTrials.gov study NCT03422393. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02629809. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03617484. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL
ClinicalTrials.gov study NCT02973399. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia
ClinicalTrials.gov study NCT04061512. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
ClinicalTrials.gov study NCT06271616. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.